An article I co-wrote in 1997 with Dr. James Heckman on the economics of using a novel technology to stimulate bone healing was quoted in a research paper published in the journal Nature, Efficacy of Electrical Stimulators for Bone Healing: A Meta-Analysis of Randomized Sham-Controlled Trials. The section quotes, “The socioeconomic burden associated with bone healing complications such as delayed union or nonunion is substantial and includes direct treatment costs as well as personal and societal costs, such as lost wages, decreased productivity and delays returning to work.”
Jane cited in Nature magazine on the economics and value of medical technology – a blast from the past!
By Jane Sarasohn-Kahn on 19 August 2016 in
I was interviewed live on BNN Bloomberg (Canada) on the market for GLP-1 drugs for weight loss and their impact on both the health care system and consumer goods and services -- notably, food, nutrition, retail health, gyms, and other sectors.
Looking forward to speaking at OSF Healthcare's first digital summit to highlight the growing movement of healthcare-to-home, empowering and supporting patients for self-care, and bolstering community health citizen-by-citizen, clinician-by-clinician.
I had a wide-ranging conversation with WCBU reporter Collin Schopp to discuss the role of telehealth in health care to expand access, equity, quality, clinician well-being and patient engagement. We spoke in advance of my keynote speech to be delivered at the inaugural OSF Digital Health Symposium on October 16, 2024, in Peoria, IL.